BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25015333)

  • 21. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
    Nguyen VN; Mirejovský P; Mirejovský T; Melínová L; Mandys V
    Acta Histochem; 2000 Aug; 102(3):323-38. PubMed ID: 10990069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA and Bone Cancer.
    Nugent M
    Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.
    Sannino G; Marchetto A; Ranft A; Jabar S; Zacherl C; Alba-Rubio R; Stein S; Wehweck FS; Kiran MM; Hölting TLB; Musa J; Romero-Pérez L; Cidre-Aranaz F; Knott MML; Li J; Jürgens H; Sastre A; Alonso J; Da Silveira W; Hardiman G; Gerke JS; Orth MF; Hartmann W; Kirchner T; Ohmura S; Dirksen U; Grünewald TGP
    EBioMedicine; 2019 Sep; 47():156-162. PubMed ID: 31427232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
    Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
    Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous and subcutaneous Ewing sarcoma.
    Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
    Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis.
    Papadopoulos O; Betsi E; Tsakistou G; Frangoulis M; Kouvatseas G; Anagnostakis D; Kouvidou Ch
    Anticancer Res; 2007; 27(4B):2167-74. PubMed ID: 17695500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA-ZDHHC8P1 promotes the progression and metastasis of colorectal cancer by targeting miR-34a.
    Li C; Liu T; Zhang Y; Li Q; Jin LK
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1476-1486. PubMed ID: 30840269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS.
    Cohen IJ; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Feinmesser M; Avigad S; Ash S
    Cancer Chemother Pharmacol; 2019 May; 83(5):859-866. PubMed ID: 30770960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
    Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
    Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.
    Dylla L; Jedlicka P
    PLoS One; 2013; 8(4):e63032. PubMed ID: 23638178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecule inhibition of Ewing sarcoma cell growth via targeting the long non coding RNA HULC.
    Mercatelli N; Fortini D; Palombo R; Paronetto MP
    Cancer Lett; 2020 Jan; 469():111-123. PubMed ID: 31639426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
    Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer.
    Raychaudhuri M; Bronger H; Buchner T; Kiechle M; Weichert W; Avril S
    Breast Cancer Res Treat; 2017 Apr; 162(3):511-521. PubMed ID: 28181130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.
    Sgambato A; Migaldi M; Faraglia B; De Aloysio G; Ferrari P; Ardito R; De Gaetani C; Capelli G; Cittadini A; Trentini GP
    Int J Cancer; 2002 Feb; 97(5):671-8. PubMed ID: 11807796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer Cells.
    Sun C; Zhang S; Liu C; Liu X
    Cancer Biother Radiopharm; 2019 Dec; 34(10):634-641. PubMed ID: 31539270
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
    Hui WT; Ma XB; Zan Y; Wang XJ; Dong L
    Chin Med J (Engl); 2015 Oct; 128(19):2632-7. PubMed ID: 26415802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis.
    Ogawa T; Saiki Y; Shiga K; Chen N; Fukushige S; Sunamura M; Nagase H; Hashimoto S; Matsuura K; Saijo S; Kobayashi T; Horii A
    Cancer Sci; 2012 Sep; 103(9):1737-43. PubMed ID: 22624980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
    Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
    Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.